Effect of repeated oral administrations of the oral adsorbent AST-120 on serum creatinine and other markers of renal function: A randomized controlled study in patients with chronic kidney disease

American Journal of Nephrology

Volumn 26, Issue 2, 2006, Pages 136-141

  Marier, Jean Francois ^a   Lee, James ^b   Prasad Kambhampati, Siva Rama ^a   Galitz, Lawrence ^c   Vargas, Ramon ^a   Moberly, James ^b   Salazar, Daniel E ^b  

^a MDS Inc   (Canada)

^b DAIICHI SANKYO INC   (United States)

^c SFBC International   (United States)

Author keywords

AST 120; Chronic kidney disease; Oral adsorbent; Renal function; Serum creatinine

Indexed keywords

ADSORBENT; AST 120; CREATININE; MARKER; MICROCRYSTALLINE CELLULOSE; PLACEBO;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DIARRHEA; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG BINDING; DRUG EFFICACY; FLATULENCE; HUMAN; KIDNEY FUNCTION; NECK PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THORAX PAIN; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CARBON; CREATININE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MODELS, BIOLOGICAL; OXIDES; TREATMENT OUTCOME;

EID: 33745089703     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092242     Document Type: Article

References (15)

1. Koide K, Sano M, Takeda F, Momose T, Koshikawa S, Akizawa T: A study of oral adsorbent in chronic renal failure. Biomater Artif Cells Immobilization Biotechnol 1991;19:147-166.
2. Koide K, Koshikawa S, Yamane Y, Hidaka S, Sekino H, Saito M, Kaneda H, Matsui N, Asano Y, Odaka M, Irie Y, Nakazawa R, Sanjo T, Tagawa H, Kawaguchi Y, Kato E, Ota K, Sugino N, Nakagawa S, Ohono J, Nakamura K, Takahashi S, Akiba T, Nagasawa T, Ishida H, Maeda T, Mimura N, Sasaoka T, Sakai H, Sakai T, Hidai H, Arakawa M, Hirasawa Y, Miyamura S, Honda N, Shibata M, Shirai D, Minakata T, Fujita K, Ishikawa H, Ohsawa G, Fujimi S: Clinical evaluation of AST-120 on suppression of progression of chronic renal failure - multi-center, double-blind study in comparison with placebo. Clin Eval 1987;15:527-564.
3. Ringoir S: An update on uremic toxins. Kidney Int 1997;52(suppl 62):S2-S4.
4. Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, Maeda K: Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 1991;57:84-88.
5. Yoshida Y, Sakai T, Ise M: Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992;62:305-314.
6. Okada K, Shibahara H, Takahashi S: Effect of oral adsorbent on the progression of diabetic nephropathy. Nephron 1997;76:489-490.
7. Aoyama I, Niwa T: An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Am J Kidney Dis 2001;37:87-812.
8. Ishikawa I, Araya M, Hayama T, Sugano M, Yamato H, Ise M: Effect of oral adsorbent (AST-120) on renal function, acquired renal cysts and aortic calcification in rats with adriamycin nephropathy. Nephron 2002;92:399-406.
9. Sakai T, Kumano K, Takara S, Kuwao S, Ise M, Sugano M, Uehara Y: Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats. Nippon Jinzo Gakkai Shi 1989;31:359-365.
10. Kumano K, Sakai T, Kuwao S, Ise M: Dietary protein loading and the oral adsorbent AST-120 in the progression of chronic renal failure in the rat. Int J Artif Organs 1992;15:708-714.
11. Sanaka T, Akizawa T, Koide K, Koshikawa S: Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy. Ther Apher Dial 2004;8:232-240.
12. Sanaka T, Sugino N, Teraoka S, Ota K: Therapeutic effects of oral sorbent in undialyzed uremia. Am J Kidney Dis 1988;12:97-103.
13. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T: Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Kidney Int Suppl 1997;63:188-190.
14. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Ronde R, Raz I, Collaborative Study Group: Reno-protective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.
15. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869.